The University of Kansas Cancer Center - Overland Park

Overland Park, Kansas 66210

1 studies enrolling now · 7 studies all time

What they study most

Acute Myeloid Leukemia, Breast Cancer, HER2-positive Breast Cancer, Hodgkin Disease, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, T-Cell, Peripheral, Melanoma, Metastatic Breast Cancer, Myelodysplastic Syndrome, Triple Negative Breast Cancer

Studies at this site

• A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies — Recruiting now
• A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer — Running, not enrolling
• A Safety Study of PF-08046044/SGN-35C in Adults With Advanced Cancers — Stopped early
• Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer — Running, not enrolling
• Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC — Running, not enrolling
• A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma — Running, not enrolling
• Palbociclib After CDK and Endocrine Therapy (PACE) — Running, not enrolling